NYMC Faculty Publications
Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection.
DOI
10.1016/j.jstrokecerebrovasdis.2020.105011
Journal Title
Journal of Stroke and Cerebrovascular Diseases
First Page
105011
Last Page
105011
Document Type
Case Report
Publication Date
9-1-2020
Department
Radiology
Second Department
Neurosurgery
Keywords
Adult, Betacoronavirus, COVID-19, Cerebral Arteries, Coronavirus Infections, Female, Headache Disorders, Primary, Host-Pathogen Interactions, Humans, Pandemics, Pneumonia, Viral, Risk Factors, SARS-CoV-2, Subarachnoid Hemorrhage, Syndrome, Vasoconstriction, Vasodilation, Vertebral Artery Dissection
Disciplines
Cardiology | Critical Care | Infectious Disease | Medicine and Health Sciences | Neurosurgery | Quality Improvement | Radiology
Abstract
The current COVID-19 pandemic has recently brought to attention the myriad of neuro- logic sequelae associated with Coronavirus infection including the predilection for stroke, particularly in young patients. Reversible cerebral vasoconstriction syndrome (RCVS) is a well-described clinical syndrome leading to vasoconstriction in the intracranial vessels, and has been associated with convexity subarachnoid hemorrhage and occasionally cervical artery dissection. It is usually reported in the context of a trigger such as medications, recreational drugs, or the postpartum state; however, it has not been described in COVID-19 infection. We report a case of both cervical vertebral artery dissection as well as convexity subarachnoid hemorrhage due to RCVS, in a patient with COVID-19 infection and no other triggers.
Recommended Citation
Dakay, K., Kaur, G., Gulko, E., Santarelli, J., Bowers, C., Mayer, S. A., Gandhi, C. D., & Al-Mufti, F. (2020). Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection.. Journal of Stroke and Cerebrovascular Diseases, 29 (9), 105011-105011. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105011
